iomeprol has been researched along with Ventricular Fibrillation in 4 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
Ventricular Fibrillation: A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ioxilan has the least arrythmogenic property among the current low-osmolality nonionic CMs." | 5.31 | The risk of contrast media-induced ventricular fibrillation is low in canine coronary arteriography with ioxilan. ( Fujiki, M; Misumi, K; Miura, N; Sakamoto, H; Tateno, O, 2000) |
| "Ioxilan has the least arrythmogenic property among the current low-osmolality nonionic CMs." | 1.31 | The risk of contrast media-induced ventricular fibrillation is low in canine coronary arteriography with ioxilan. ( Fujiki, M; Misumi, K; Miura, N; Sakamoto, H; Tateno, O, 2000) |
| "Iomeprol for injection is a new nonionic triiodinated contrast medium for diagnostic radiology, which combines low osmolality with low viscosity." | 1.29 | Pharmacodynamic effects of iomeprol for injection in experimental animals. ( Cipolla, P; de Haën, C; Luzzani, F; Tirone, P, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mottard, N | 1 |
| Mewton, N | 1 |
| Bonnefoy, E | 1 |
| Abdellaoui, M | 1 |
| Revel, D | 1 |
| Kirkorian, G | 1 |
| Chai, CM | 1 |
| Karlsson, JO | 1 |
| Almén, T | 1 |
| Cipolla, P | 1 |
| Tirone, P | 1 |
| Luzzani, F | 1 |
| de Haën, C | 1 |
| Misumi, K | 1 |
| Tateno, O | 1 |
| Fujiki, M | 1 |
| Miura, N | 1 |
| Sakamoto, H | 1 |
4 other studies available for iomeprol and Ventricular Fibrillation
| Article | Year |
|---|---|
Acute myocarditis mimicking lateral myocardial infarction.
Topics: Acute Disease; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Chest Pain; Co | 2008 |
Incidence of ventricular fibrillation during left coronary arteriography in pigs: comparison of a solution of the nonionic dimer iodixanol with solutions of five different nonionic monomers.
Topics: Animals; Catheterization; Contrast Media; Coronary Angiography; Coronary Vessels; Electrolytes; Fema | 2008 |
Pharmacodynamic effects of iomeprol for injection in experimental animals.
Topics: Animals; Blood Circulation; Blood Coagulation; Blood Pressure; Blood-Brain Barrier; Brain; Cardiac O | 1994 |
The risk of contrast media-induced ventricular fibrillation is low in canine coronary arteriography with ioxilan.
Topics: Animals; Contrast Media; Coronary Angiography; Dog Diseases; Dogs; Female; Iohexol; Iopamidol; Male; | 2000 |